MDGL Financing Cash Flow
Madrigal Pharmaceuticals Inc · Financing Cash Flow
MDGL Financing Cash Flow
Latest reported$251.04Mperiod ending
MDGL TTM Cash from Financing ($43.88M → $251.04M)
TTM financing cash flow
High-resolution chart · PNG
MDGL financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 251,044,000 | |
| 249,673,000 | |
| 255,984,000 | |
| 266,799,000 | |
| 37,614,000 | |
| 169,996,000 | |
| 735,062,000 | |
| 1,195,207,000 | |
| 1,207,325,000 | |
| 1,116,132,000 | |
| 595,116,000 | |
| 379,537,000 | |
| 359,957,000 | |
| 366,141,000 | |
| 313,451,000 | |
| 68,617,000 | |
| 89,716,000 | |
| 104,143,000 | |
| 171,237,000 | |
| 156,363,000 | |
| 135,614,000 | |
| 72,182,000 | |
| 5,088,000 | |
| 459,000 | |
| 144,000 | |
| 152,000 | |
| 235,000 | |
| 845,000 | |
| 1,261,000 | |
| 314,153,000 | |
| 314,335,000 | |
| 449,252,000 | |
| 448,801,000 | |
| 170,671,000 | |
| 173,805,000 | |
| 44,231,832 | |
| 57,350,082 | |
| 20,171,082 | |
| 14,454,082 | |
| 6,184,250 | |
| -1,418,000 | |
| 40,379,000 | |
| 40,386,000 | |
| 40,393,000 | |
| 60,692,000 | |
| 75,368,000 | |
| 85,296,000 | |
| 144,458,000 | |
| 118,432,000 | |
| 64,379,000 | |
| 69,042,000 | |
| 70,262,000 | |
| 94,424,000 | |
| 94,745,000 | |
| 115,515,000 | |
| 57,373,000 | |
| 33,287,000 | |
| 67,683,000 | |
| 36,736,000 | |
| 41,901,000 | |
| 55,992,000 | |
| 20,908,000 | |
| 45,156,000 | |
| 39,677,000 | |
| 25,216,000 | |
| 24,872,000 | |
| -2,129,000 | |
| -2,399,000 | |
| -2,598,000 | |
| -2,300,000 | |
| -1,906,000 | |
| -1,522,000 | |
| -939,000 | |
| -1,098,000 | |
| 43,883,000 | |
| 43,960,000 | |
| 43,400,000 |